Author:
Gu Shuang-Xi,Chen Jiong,Zhu Yuan-Yuan,Ming Wei,Zhang Shuang-Shuang,Cao Jin-Xu
Reference129 articles.
1. Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years;Zhuang;Acta Pharm. Sin. B,2020
2. Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors;Gu;Eur. J. Med. Chem.,2018
3. Development of selective DprE1 inhibitors: design, synthesis, crystal structure and antitubercular activity of benzothiazolylpyrimidine-5-carboxamides;Chikhale;Eur. J. Med. Chem.,2015
4. Synthesis, characterization and in-vitro anti-inflammatory activity of some substituted 1,2,3,4-tetrahydropyrimidine derivatives;Gondkar;Drug Invent. Today,2013
5. Synthesis of new pyrimidine-fused derivatives as potent and selective antidiabetic alpha-glucosidase inhibitors;Panahi;Carbohydr. Res.,2013